FDA orders Lancôme to 'tone down' its advertising for new anti-ageing cream

A cosmetics giant has been told to remove marketing claims from its website that its anti-ageing products can "boost the activity of genes". Lancôme, which produces a range of skincare products including youth activating night cream and youth activating cream serum, has been told by the US Food and Drug Administration (FDA) that some of the marketing claims used on its American website must be removed.The FDA conducted a review of Lancôme's website in August. It concluded that the company's claim that its Genifique Repair youth activating night cream "boosts the activity of genes" broke the FDA code as the skincare cream is not an approved drug. It retails at £60 for just under 50ml. A letter to Lancôme from the FDA said: "Your products are not generally recognised among qualified experts as safe and effective for the above referenced uses". The FDA has ordered the company to "take prompt action to correct all violations". Failure to do so could see enforcement action taken against the cosmetics firm, with the products being removed from sale in the United States. A spokesman for L'Oreal, Lancôme's parent company, told the Wall Street Journal that it had received the FDA's letter and would respond. "Lancôme is committed to complying fully with all laws and regulatory standards," it said. See original story here: http://www.dailymail.co.uk/femail/article-2204536/Lanc-slapped-FDA-warning-ad-anti-ageing-range-claims-boost-activity-genes.html